Gesundheitsökonomie und Medizinmanagement, Hochschule Neubrandenburg, Brodaer Straße 2, 17033, Neubrandenburg, Germany.
Gesellschaft Für Empirische Beratung GmbH (GEB), Freiburg, Germany.
Eur J Health Econ. 2021 Apr;22(3):425-443. doi: 10.1007/s10198-021-01264-6. Epub 2021 Feb 15.
There are unresolved procedural and medical problems in the care of diabetes, which cause high costs for health systems. These include the inadequate glycemic adjustment, care gaps, therapeutic inertia, and a lack of motivation. Personalized diabetes management can be seen as a kind of "standard process" that provides both physicians and patients with a framework. The aim of this empirical survey is the evaluation of patient preferences regarding personalized diabetes management. The purpose of this experiment is to demonstrate the properties of the programs that are relevant for the choice of insulin-based therapy regimens for patients with type II diabetes mellitus.
A discrete choice experiment (DCE) was applied to identify preferences for a personalized diabetes management in patients with type II diabetes mellitus. Six attributes were included. The DCE was conducted in June 2017 using a fractional factorial design, and the statistical data analysis used random effect logit models.
N = 227 patients (66.1% male) were included. The preference analysis showed dominance for the attribute "occurrence of severe hypoglycemias per year" [level difference (LD) 2765]. Preference analysis also showed that participants weight the "risk of myocardial infarction (over 10 years)" (LD 1.854) highest among the side effects. Within the effectiveness criterion of "change in the long-term blood glucose level (HbA1c)" a change at an initial value of 9.5% (LD 1.146) is weighted slightly higher than changes at 7.5% (LD 1.141). Within the random parameter logit estimation, all coefficients proved to be significantly different from zero at the level p ≤ 0.01. The latent class analysis shows three heterogeneous classes, each showing clearly different weights of the therapeutic properties. This results in a clear three-folding: for 1/3 of the respondents the change of the long-term blood sugar (HbA1c value) is the top objective. Another third is solely interested in the short-term effectiveness of the therapy in the sense of the occurrence of severe hypoglycemias per year. The last third of the interviewees finally focuses on the follow-up regarding cardiovascular events. Overall, there were five structural and personality traits which have an influence on the respective probability of the class membership.
DISCUSSION/CONCLUSION: This study identifies and weights the key decision-making criteria for optimal management of diabetes from the perspective of patients. It was shown that the effectiveness of a care program is the most important from the perspective of the patient and avoiding severe a hypoglycemia has the greatest influence on the choice. The risk of myocardial infarction as a follow-up disease and the long-term adjustment of the blood glucose follow the importance. In the analysis of possible subgroup differences by means of latent class analysis, it was found that three preference patterns exist within the sample. The generated preference data can be used for the design of personalized management approaches. It remains open to the extent to which expert opinions and patient preferences diverge.
糖尿病的护理存在程序和医学方面的未解决问题,这导致医疗系统成本高昂。这些问题包括血糖控制不充分、护理差距、治疗惰性以及缺乏动力。个性化糖尿病管理可以被视为一种“标准流程”,为医生和患者提供了一个框架。本实证调查旨在评估患者对个性化糖尿病管理的偏好。该实验的目的是展示与选择基于胰岛素的治疗方案相关的程序特性,适用于 2 型糖尿病患者。
采用离散选择实验(DCE)来确定 2 型糖尿病患者对个性化糖尿病管理的偏好。纳入了 6 个属性。DCE 于 2017 年 6 月采用分面设计进行,并使用随机效应对数模型进行统计数据分析。
共纳入 227 例患者(66.1%为男性)。偏好分析显示,“每年严重低血糖的发生次数”这一属性具有优势[水平差异(LD)为 2765]。偏好分析还表明,参与者对“心肌梗死风险(超过 10 年)”(LD 为 1.854)这一副作用的重视程度最高。在“长期血糖水平(HbA1c)变化”的有效性标准内,初始值为 9.5%(LD 为 1.146)的变化比初始值为 7.5%(LD 为 1.141)的变化略高。在随机参数对数模型估计中,所有系数在 p 值≤0.01 时均显著不同于零。潜在类别分析显示,存在三个异质类别,每个类别都表现出明显不同的治疗属性权重。这导致了明显的三分法:对于 1/3 的受访者而言,长期血糖(HbA1c 值)的变化是首要目标。三分之一的人仅对每年严重低血糖的发生次数这一治疗的短期有效性感兴趣。最后三分之一的受访者最终关注心血管事件的随访情况。总体而言,有五个结构和人格特征对各自类别的成员概率有影响。
讨论/结论:本研究从患者的角度确定并权衡了糖尿病最佳管理的关键决策标准。结果表明,从患者的角度来看,治疗方案的有效性是最重要的,避免严重低血糖对选择的影响最大。心肌梗死作为后续疾病的风险以及长期血糖调整紧随其后。通过潜在类别分析对可能的亚组差异进行分析,发现样本中存在三种偏好模式。生成的偏好数据可用于设计个性化管理方法。专家意见和患者偏好之间的分歧程度仍有待进一步探讨。